Message from Paradigm’s President, Catherine Veal
What a whirlwind this Spring has been for us all! At Paradigm, we’ve stayed very busy throughout the COVID-19 public health emergency and we’re looking forward to helping our clients as they continue telemedicine visits and return to in-person encounters with their patients. Our Benchmark® Presumptive LC-MS/MS testing platforms (oral and urine) continue to serve as efficient and cost-effective tools to mitigate risks associated with treating patients with controlled medication or treating them for substance use disorders. Whatever your practice background, we hope you will continue to look to us for quality toxicology testing.
We are dedicating this issue of The Paradigm Shift to providing you with an overview of the laboratory data we compile for client use in evaluating their patient population and controlled substance prescribing compliance efforts. We are very proud of our Information and Client Services Department and the data we compile to facilitate client education and improved laboratory test ordering.
We hope this information facilitates discussion between you and your Paradigm Account Executive about your practice needs and Paradigm’s laboratory services can better serve you and your patients. If you have a topic you would like us to discuss or a question, let us know. We look forward to continuing to serve you and working together to get through these challenging times!
To view the June 2020 newsletter, click here.
